Material Litigation Update
Paradeep Phosphates Faces Setback as NCLAT Rejects Entry Tax Exemption Appeal
NSE
paradeep
BSE
543530
Paradeep Phosphates Limited informed exchanges that the National Company Law Appellate Tribunal (NCLAT) has dismissed the company’s appeal relating to Entry Tax exemption claims under a BIFR-sanctioned rehabilitation scheme in Odisha. The company has already provided for the liability in its books and plans to approach the Supreme Court.
PRICE-SENSITIVE TRIGGER
Event: NCLAT Dismisses Appeal in Entry Tax Litigation
Type: Material Litigation Update
Impact: Negative
Immediate Effect: The appellate tribunal’s rejection weakens the company’s legal position in the long-running Entry Tax exemption dispute, although management stated no material financial impact is expected currently.

Key Metrics:
- Total Tax Demand/Liability: ₹76 crore
- Amount Deposited Under Protest: ₹26 crore
- Period Under Dispute: 2007–2014
- Claimed Exemption Period: 2007–2011
Highlight Metric:
- Paradeep Phosphates has already fully provided for the liability in its books and deposited ₹26 crore under protest against the total demand of ₹76 crore.
What Happened ?
Paradeep Phosphates Limited disclosed that the National Company Law Appellate Tribunal (NCLAT) rejected the company’s appeal seeking Entry Tax exemption in Odisha under a rehabilitation scheme sanctioned by BIFR under the Sick Industrial Companies (Special Provisions) Act, 1985.
The litigation pertains to the company’s claim for exemption/remission from Entry Tax between 2007 and 2014. The company had argued that it was eligible for exemption during the period when it was classified as a sick industrial company.
NCLAT upheld the earlier NCLT order rejecting the company’s plea. Paradeep Phosphates stated it will now take appropriate legal steps and file an appeal before the Hon’ble Supreme Court.
The company also clarified that no material impact on current financials is expected.
Key Details
Litigation Background:
- The opposing parties are the State of Odisha and related tax authorities.
- The matter was heard before the National Company Law Appellate Tribunal (NCLAT), Principal Bench, New Delhi.
- The dispute relates to Entry Tax exemption/remission claims under a BIFR-approved rehabilitation package.
Financial Exposure:
- Total liability/demand stands at approximately ₹76 crore.
- The company has deposited ₹26 crore under protest.
- Paradeep Phosphates has already made provisions for the liability in its books.
- Any additional interest impact on the unpaid amount is not expected to be material.
Tribunal Outcome:
- NCLAT upheld the earlier NCLT order rejecting the exemption claim.
- The company’s appeal stands dismissed.
- Management intends to challenge the ruling before the Supreme Court.
Management Position:
- The company continues to maintain that it is eligible for Entry Tax remission for the 2007–2011 period.
- Paradeep Phosphates stated that no material financial impact is expected currently despite the adverse order.
Note:
- The dispute originates from tax exemptions linked to the company’s rehabilitation phase under BIFR before it exited sick industrial status in August 2021.
Risk Analysis
Key Risks:
- Adverse judicial outcomes in higher courts may require additional payouts.
- Potential interest liabilities may arise depending on final court rulings.
- Prolonged litigation could create sentiment-related pressure for investors.
- Regulatory disputes may impact perception regarding legacy tax matters.
Worst Case Scenario:
- If the Supreme Court also rules against the company and authorities pursue the full tax demand with additional penalties or interest, Paradeep Phosphates may face incremental cash outflows beyond current provisions.
Risk Level: Medium
Company Commentary
- The company stated it has already fully provided for the liability in its books.
- Paradeep Phosphates believes it remains eligible for Entry Tax remission during the rehabilitation period.
- Management confirmed that appropriate legal steps are being taken to appeal before the Supreme Court.
- The company reiterated that no material financial impact is expected currently.
Official Exchange Filing: Paradeep Phosphates Limited